Skip to main content
Clinical Trials/CTRI/2022/04/041954
CTRI/2022/04/041954
Completed
N/A

A clinical study to evaluate the effectiveness of Sarvtobhadra vati in the patients of stage I, II and III of chronic renal failure.

J S Ayurveda Mahavidhyalaya0 sites20 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
J S Ayurveda Mahavidhyalaya
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 11, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
J S Ayurveda Mahavidhyalaya

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients of stage I, II or III of chronic renal failure (eGFR not less than 30 ml/min/1\.73m2\).
  • 2\.Patients having age between 18 to 65 years of both genders will be included for the study.
  • 3\.Serum creatinine less than3\.0 mg/dl.

Exclusion Criteria

  • 1\.Patients who are on dialysis treatment. Patients who are already operated for renal transplantation and then having nephropathy.
  • 2\.Patients of hepato\-renal insufficiency or renal insufficiency due to haemodynemic circulatory disorders and CCF.
  • 3\.Patients with some serious illness like cardio\-vascular diseases, psychological disorders, serious acute organic diseases, serious chronic co\-morbidities, liver disorders or metabolic disorders etc
  • 4\.Female patients having pregnancy, breast feeding or post\-delivery period.

Outcomes

Primary Outcomes

Not specified

Similar Trials